Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus sufentanil as adjuvants to bupivacaine for brachial plexus block
DRKS00024182Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Group S: sufentanil + bupivacaine with Group D: dexmedetomidine + bupivacaine (2 arms). Started Jan 2021; status: completed.
02
Drugs
dexmedetomidinesufentanilbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on DRKS00024182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024182.